ConductScience.org, home

Paper39350146

Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis.

Totoki T and 6 others. Thromb J, 2024. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis. Papers, record 39350146. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39350146

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis.
PubMed
Journal
Thromb J
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
2.15, provisional
iCite
Revised in PubMed
2024-10-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Totoki TTakaaki
2Koami HHiroyuki
3Makino YYuto
4Wada TTakeshi
5Ito TTakashi
6Yamakawa KKazuma
7Iba TToshiaki

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137359014Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy.Front Med (Lausanne)2023https://conductscience.org/library/papers/37359014PubMed
233824483Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.Nat Rev Immunol2021https://conductscience.org/library/papers/33824483PubMed
325493972The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis.Crit Care Med2015https://conductscience.org/library/papers/25493972PubMed
432558075Coagulopathy in COVID-19.J Thromb Haemost2020https://conductscience.org/library/papers/32558075PubMed
530449812Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation.Intern Med2019https://conductscience.org/library/papers/30449812PubMed
631462531RoB 2: a revised tool for assessing risk of bias in randomised trials.BMJ2019https://conductscience.org/library/papers/31462531PubMed
734617959
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
JAMA Intern Med2021https://conductscience.org/library/papers/34617959PubMed
831954465Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.Lancet2020https://conductscience.org/library/papers/31954465PubMed
933186991Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.Thromb Haemost2020https://conductscience.org/library/papers/33186991PubMed
1035836009Race does matter: venous thromboembolism in trauma patients with isolated severe pelvic fractures.Eur J Trauma Emerg Surg2023https://conductscience.org/library/papers/35836009PubMed
1115221932Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2).J Pathol2004https://conductscience.org/library/papers/15221932PubMed
1237256226Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy.Front Pharmacol2023https://conductscience.org/library/papers/37256226PubMed
1326903338The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).JAMA2016https://conductscience.org/library/papers/26903338PubMed
1433782057The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.BMJ2021https://conductscience.org/library/papers/33782057PubMed
1527181297Efficacy and safety of low-molecular-weight heparin in patients with sepsis: a meta-analysis of randomized controlled trials.Sci Rep2016https://conductscience.org/library/papers/27181297PubMed
1627479532Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.Thromb Res2016https://conductscience.org/library/papers/27479532PubMed
1733095849
Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
JAMA2020https://conductscience.org/library/papers/33095849PubMed
1835062871Unfractionated heparin improves the clinical efficacy in adult sepsis patients: a systematic review and meta-analysis.BMC Anesthesiol2022https://conductscience.org/library/papers/35062871PubMed
1925023776
Unfractionated heparin suppresses lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human microvascular endothelial cells by blocking Krüppel-like factor 5 and nuclear factor-κB pathway.
Immunobiology2014https://conductscience.org/library/papers/25023776PubMed
20126642192001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Intensive Care Med2003https://conductscience.org/library/papers/12664219PubMed

See all 32 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42973830Opening the Door for the New Era of Managing Sepsis-induced Coagulopathy.Juntendo Med J2026https://conductscience.org/library/papers/42973830PubMed
42903397Anticoagulants beyond coagulation: repurposing heparin to mitigate immunothrombosis and inflammatory cascades in sepsis.Front Pharmacol2026https://conductscience.org/library/papers/42903397PubMed
42851353Longitudinal sepsis-induced coagulopathy score trajectories and mortality in relation to early prophylactic heparin: a multicentre cohort study.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42851353PubMed
42835425Early systemic heparin exposure is associated with lower mortality, reduced disseminated intravascular coagulation, and fewer thrombotic complications in septic shock.Front Med (Lausanne)2026https://conductscience.org/library/papers/42835425PubMed
42286503The U-shaped relationship between triglyceride glucose-body mass index and prognosis of sepsis patients: a retrospective study.BMC Infect Dis2026https://conductscience.org/library/papers/42286503PubMed
41901308Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41901308PubMed
41598427Recognizing Coagulation Disorders in Sepsis in the Emergency Room: A Narrative Review.J Clin Med2026https://conductscience.org/library/papers/41598427PubMed
41331689Efficacy and safety of anticoagulant therapy in patients with sepsis: a meta-analysis of randomized controlled trials.Thromb J2025https://conductscience.org/library/papers/41331689PubMed
41306966Influence of heparin-based anticoagulants on antibiotic therapy.Front Immunol2025https://conductscience.org/library/papers/41306966PubMed
41193583The impact of continuous intravenous administration of heparin on coagulation dysfunction and organ failure in patients with sepsis.Sci Rep2025https://conductscience.org/library/papers/41193583PubMed
40740948
Reevaluating anticoagulation therapy for sepsis-associated disseminated intravascular coagulation based on endothelial glycocalyx shedding quantification: a single-center, retrospective, observational pilot study.
Front Med (Lausanne)2025https://conductscience.org/library/papers/40740948PubMed
40083381Unfractionated heparin may improve near-term survival in patients admitted to the ICU with sepsis attributed to pneumonia: an observational study using the MIMIC-IV database.Front Pharmacol2025https://conductscience.org/library/papers/40083381PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39350146

GET https://conductscience.org/api/papers/v1/39350146/references?page=2